Objetivo Medications are one of the most common healthcare interventions and one with great risk of adverse events and serious harm to patients. Medications incidents in hospitals are frequent and a serious concern. Electronic medicine management systems (EMMS) implemented in hospital are known to reduce some safety risks but also introduce new ones. A way to prevent harm to patients from the use of medication is through organising for collective mindfulness (alertness to risks) and through learning from everyday resilience. EMMS introduced in sociotechnical contexts of hospital care may affect collective mindfulness and resilience, in ways that are context (or nation) specific, as countries differ in structures, processes, and legislation.This project proposes a collaboration with Australian and European centres of excellence in the field of patient safety, to study mindfulness and resilience in medication safety in relation to EMMS. As part of the research, a mixed-method before-and-after study of EMMS implementation will be conducted in hospitals in Australia, followed by a comparative study across four European countries (UK, France, Italy, Norway). The aims are to develop theory and method for EMMS evaluation, investigate whether and how EMMS can support organisational resilience in the use of medicines, and provide (locally/nationally-adjusted) guidance for implementation.The fellow brings to the study experience in sociotechnical studies informed by theories that emphasize contextual influences on cognition and decision making, and capture emergent systems’ properties/behaviours. The hosts and partners are leaders in patient safety, with expertise in human factors and mixed-methods. The research will create opportunities for professional development and knowledge exchanges and strengthen the network of participant organisations. It will deliver knowledge and instruments for the benefit of patients, clinicians, healthcare organisations and society overall. Ámbito científico medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugssocial sciencespsychologyergonomics Programa(s) H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility Tema(s) MSCA-IF-2016 - Individual Fellowships Convocatoria de propuestas H2020-MSCA-IF-2016 Consulte otros proyectos de esta convocatoria Régimen de financiación MSCA-IF-GF - Global Fellowships Coordinador UNIVERSITY COLLEGE LONDON Aportación neta de la UEn € 276 107,40 Dirección GOWER STREET WC1E 6BT London Reino Unido Ver en el mapa Región London Inner London — West Camden and City of London Tipo de actividad Higher or Secondary Education Establishments Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 276 107,40 Socios (1) Ordenar alfabéticamente Ordenar por aportación neta de la UE Ampliar todo Contraer todo Socio Las organizaciones asociadas contribuyen a la aplicación de la acción, pero no firman el acuerdo de subvención. MACQUARIE UNIVERSITY Australia Aportación neta de la UEn € 0,00 Dirección BALACLAVA ROAD NORTH RYDE 2109 Sydney Ver en el mapa Tipo de actividad Higher or Secondary Education Establishments Enlaces Contactar con la organización Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 178 380,00
